This is associated with the fact that hyperexpression of HIF-2α, which develops under hypoxia, suppresses PPARa in the liver and, consequently, aggravates the course of NAFLD [273]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.